Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 6:16:1019-1045.
doi: 10.2147/OPTH.S209395. eCollection 2022.

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review

Kamal Kishore  1   2 , Pooja V Bhat  3 , Pradeep Venkatesh  4 , Cecilia C Canizela  2
Affiliations
Review

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review

Kamal Kishore et al. Clin Ophthalmol. .

Abstract

Purpose: The purpose of this review article is to provide a comprehensive review of the current applications of intravitreal DEX implant (Ozurdex®, Allergan Inc, Irvine, CA) for a variety of ophthalmic conditions - ranging from FDA approved indications to off-label uses. We have attempted to provide relevant evidence from the literature to help a reader develop an understanding of the biological and pharmacokinetic properties of DEX implant, its uses, and potential side effects.

Methods: PubMed searches were performed using the terms "Ozurdex", or "intravitreal DEX implant", AND "retinal vein occlusion", or "diabetic macular edema", or "uveitis". The search was performed in July of 2021, with an additional search in October 2021. All original English language articles were considered for this review.

Results: DEX implant has evidence of efficacy in a variety of clinical situations including macular edema associated with retinal vein occlusion, diabetes, uveitis, and others. Safety concerns include cataract formation and progression, intraocular pressure elevation, complications related to intravitreal injection, and opportunistic infections secondary to steroid-induced immune suppression.

Conclusion: DEX implant is a useful tool in the management of several retinal disorders. Further studies are needed for head-to-head comparison with other treatment modalities and to determine its precise place in clinical practice.

Keywords: Ozurdex; diabetic macular edema; intravitreal DEX implant; retinal vein occlusion; uveitic macular edema; uveitis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Ultra-wide field image showing dexamethasone implant in the inferior vitreous in a patient with lasered proliferative diabetic retinopathy and recurrent macular edema.
Figure 2
Figure 2
(A) Persistent macular edema in an eye with superotemporal branch retinal vein occlusion despite 9 intravitreal bevacizumab, 17 ranibizumab, and 3 grid laser treatments over 61 months. (B) Resolution of macular edema one month after DEX implant.
Figure 3
Figure 3
(A) Fundus photo of an eye with intermediate uveitis showing marked vitreous haze and membranes. (B) Marked macular edema and subretinal fluid on OCT. (C) Three days after DEX implant showing marked improvement in vitreous haze and membranes. (D) Resolution of macular edema.
Figure 4
Figure 4
(A) Diabetic macular edema persistent after 10 intravitreal bevacizumab and 13 aflibercept injections over 40 months. (B) Resolution of macular edema one month after DEX implant.
See this image and copyright information in PMC

References

    1. Nauck M, Karakiulakis G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 1998;341(2–3):309–315. doi: 10.1016/S0014-2999(97)01464-7 - DOI - PubMed
    1. Penfold PL, Wen L, Madigan MC, et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol. 2000;121(3):458–465. doi: 10.1046/j.1365-2249.2000.01316.x - DOI - PMC - PubMed
    1. Singer KL, Stevenson BR, Woo PL, et al. Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells. J Biol Chem. 1994;269(23):16108–16115. - PubMed
    1. Antonetti DA, Wolpert EB, DeMaio L, et al. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem. 2002;80(4):667–677. doi: 10.1046/j.0022-3042.2001.00740.x - DOI - PubMed
    1. Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res. 2005;80(2):249–258. doi: 10.1016/j.exer.2004.09.013 - DOI - PubMed